NO984651L - Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet - Google Patents

Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet

Info

Publication number
NO984651L
NO984651L NO984651A NO984651A NO984651L NO 984651 L NO984651 L NO 984651L NO 984651 A NO984651 A NO 984651A NO 984651 A NO984651 A NO 984651A NO 984651 L NO984651 L NO 984651L
Authority
NO
Norway
Prior art keywords
manufacture
treatment
nervous system
benzone
drugs
Prior art date
Application number
NO984651A
Other languages
English (en)
Norwegian (no)
Other versions
NO984651D0 (no
Inventor
Xavier Vige
Jusus Benavides
Braham Shroot
Vuronique Taupin
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NO984651D0 publication Critical patent/NO984651D0/no
Publication of NO984651L publication Critical patent/NO984651L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO984651A 1996-04-05 1998-10-05 Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet NO984651L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604359A FR2747041B1 (fr) 1996-04-05 1996-04-05 Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des neuropathies
PCT/FR1997/000590 WO1997037648A1 (fr) 1996-04-05 1997-04-02 Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des maladies du systeme nerveux

Publications (2)

Publication Number Publication Date
NO984651D0 NO984651D0 (no) 1998-10-05
NO984651L true NO984651L (no) 1998-12-03

Family

ID=9490993

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984651A NO984651L (no) 1996-04-05 1998-10-05 Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet

Country Status (23)

Country Link
US (1) US6043280A (xx)
EP (1) EP0900078B1 (xx)
JP (1) JP2000512619A (xx)
KR (1) KR20000005179A (xx)
CN (1) CN1221341A (xx)
AT (1) ATE189385T1 (xx)
AU (1) AU717704B2 (xx)
BR (1) BR9708511A (xx)
CA (1) CA2250755A1 (xx)
CZ (1) CZ317698A3 (xx)
DE (1) DE69701258T2 (xx)
ES (1) ES2144857T3 (xx)
FR (1) FR2747041B1 (xx)
GR (1) GR3033061T3 (xx)
HU (1) HUP9902167A3 (xx)
NO (1) NO984651L (xx)
NZ (1) NZ332158A (xx)
PL (1) PL329219A1 (xx)
PT (1) PT900078E (xx)
RU (1) RU2160098C2 (xx)
SK (1) SK133398A3 (xx)
WO (1) WO1997037648A1 (xx)
ZA (1) ZA972875B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials
AU1760201A (en) * 1999-11-12 2001-06-06 Fred Hutchinson Cancer Research Center Methods for treatment of human huntington's disease and methods of screening foractive agents
TWI306450B (en) * 2001-12-13 2009-02-21 Wyeth Corp Substituted phenyl naphthalenes as estrogenic agents
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
EP4066826B1 (en) 2010-09-01 2024-03-06 Thomas Jefferson University Retinoic acid receptor gamma agonists for muscle repair and regeneration
KR101981930B1 (ko) 2017-08-10 2019-05-27 주식회사 에니텍시스 랜딩 장치

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455248A (en) * 1993-09-14 1995-10-03 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts, and compositions and method of use thereof

Also Published As

Publication number Publication date
ES2144857T3 (es) 2000-06-16
ATE189385T1 (de) 2000-02-15
CZ317698A3 (cs) 1999-02-17
KR20000005179A (ko) 2000-01-25
DE69701258T2 (de) 2000-12-21
NO984651D0 (no) 1998-10-05
HUP9902167A2 (hu) 2000-04-28
RU2160098C2 (ru) 2000-12-10
SK133398A3 (en) 1999-12-10
ZA972875B (en) 1997-10-31
GR3033061T3 (en) 2000-08-31
WO1997037648A1 (fr) 1997-10-16
FR2747041A1 (fr) 1997-10-10
US6043280A (en) 2000-03-28
PL329219A1 (en) 1999-03-15
AU2392797A (en) 1997-10-29
HUP9902167A3 (en) 2000-07-28
FR2747041B1 (fr) 1998-05-22
PT900078E (pt) 2000-07-31
AU717704B2 (en) 2000-03-30
JP2000512619A (ja) 2000-09-26
EP0900078B1 (fr) 2000-02-02
EP0900078A1 (fr) 1999-03-10
DE69701258D1 (de) 2000-03-09
CN1221341A (zh) 1999-06-30
CA2250755A1 (fr) 1997-10-16
NZ332158A (en) 2000-06-23
BR9708511A (pt) 1999-08-03

Similar Documents

Publication Publication Date Title
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
NO995006L (no) Nye forbindelser
NO903088D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
AU8296987A (en) Pharmaceutical composition comprising fluticasone propionate
PT912184E (pt) Utilizacao de um derivado de k-252a para o tratamento de doencas do sietma nervoso central ou periferico e sobre-producao de citoquina
ATE218142T1 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
DE59904180D1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
DE69500673D1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
NO973531L (no) Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
AU3019389A (en) 6-oxo-4,5-dihydro-pyridazine derivatives, a process for their preparation and medicaments containing these compounds
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
TR199901385T2 (xx) Piperidin t�revleri.
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
AU3439897A (en) Pharmaceutical formulations containing colostrum and their use
DE69923117D1 (de) Verwendung von Homocysteinderivaten zur Behandlung von bakteriellen Infektionen
ATE74505T1 (de) Schmerzpraeparat.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application